Works matching IS 08991987 AND DT 2023 AND VI 62 AND IP 9
Results: 17
Cover Image, Volume 62, Issue 9.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. i, doi. 10.1002/mc.23622
- By:
- Publication type:
- Article
IL‐8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR‐146a mediated mechanism.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1428, doi. 10.1002/mc.23587
- By:
- Publication type:
- Article
Insulin‐like growth factor (IGF) and hepatocyte growth factor (HGF) in follicular fluid cooperatively promote the oncogenesis of high‐grade serous carcinoma from fallopian tube epithelial cells: Dissection of the molecular effects.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1417, doi. 10.1002/mc.23586
- By:
- Publication type:
- Article
IL‐17 induces non‐small cell lung cancer metastasis via GCN5‐dependent SOX4 acetylation enhancing MMP9 gene transcription and expression.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1399, doi. 10.1002/mc.23585
- By:
- Publication type:
- Article
The relationship of nutritional status with anticancer immunity and its prognostic value for head and neck cancer.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1388, doi. 10.1002/mc.23584
- By:
- Publication type:
- Article
Potentially functional genetic variants in RPS6KA4 and MAP2K5 in the MAPK signaling pathway predict HBV‐related hepatocellular carcinoma survival.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1378, doi. 10.1002/mc.23583
- By:
- Publication type:
- Article
Potentiated effects of lactate receptor GPR81 on immune microenvironment in breast cancer.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1369, doi. 10.1002/mc.23582
- By:
- Publication type:
- Article
An integrative analysis reveals the prognostic value and potential functions of PSMD11 in hepatocellular carcinoma.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1355, doi. 10.1002/mc.23568
- By:
- Publication type:
- Article
Tandem mass tag (TMT) quantitative protein analysis‐based proteomics and parallel reaction monitoring (PRM) validation revealed that MST4 accelerates osteosarcoma proliferation by increasing MRC2 activity.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1338, doi. 10.1002/mc.23567
- By:
- Publication type:
- Article
SUMO1 degrader induces ER stress and ROS accumulation through deSUMOylation of TCF4 and inhibition of its transcription of StarD7 in colon cancer.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1249, doi. 10.1002/mc.23560
- By:
- Publication type:
- Article
Overexpression of TYRO3 indicates poor prognosis and induces gastric cancer progression via AKT‐mTOR pathway.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1325, doi. 10.1002/mc.23566
- By:
- Publication type:
- Article
Transmembrane protein 147, as a potential Sorafenib target, could expedite cell cycle process and confer adverse prognosis in hepatocellular carcinoma.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1295, doi. 10.1002/mc.23564
- By:
- Publication type:
- Article
KRAS mutations upregulate Runx1 to promote occurrence of head and neck squamous cell carcinoma.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1284, doi. 10.1002/mc.23563
- By:
- Publication type:
- Article
Homologous recombination repair gene mutations in colorectal cancer favors treatment of immune checkpoint inhibitors.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1271, doi. 10.1002/mc.23562
- By:
- Publication type:
- Article
A two‐stage genome‐wide association study identified four potential early‐onset nonsmall cell lung cancer risk loci based on 26,652 participants in Chinese population.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1263, doi. 10.1002/mc.23561
- By:
- Publication type:
- Article
Inhibition of Wnt/β‐catenin pathway overcomes therapeutic resistance to abiraterone in castration‐resistant prostate cancer.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1312, doi. 10.1002/mc.23565
- By:
- Publication type:
- Article
Issue Information ‐ Ed Board.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1245, doi. 10.1002/mc.23431
- Publication type:
- Article